Form D · Biotechnology
Phloronol, Inc.
San Francisco, CA · CIK 0001524540
Offering snapshot reported Oct 27, 2011 · SEC filing
- Reported sold
- $290K Offering amount: $2.4M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 10, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 27, 2011 | Initial | $290,000 | No comparison | 5 | SEC filing |
| Oct 27, 2011 | Initial | $8,160,000 | No comparison | 4 | SEC filing |
| Jun 30, 2011 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-167866
Common Stock & Warrant Offering; includes common stock issuable upon exercise of warrants
Source: Form D, filed Oct 27, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Haengwoo Lee | Director, Executive |
| Chester Mac Phee | Executive |
| Justin Shimada | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
490 Post St., Suite 1700
San Francisco, CA, 94102
San Francisco, CA, 94102